| Mepha Pharma AG - Lamotrin-Mepha 25 mg, Tabletten | | 57137 | | 02 | | Lamotrin-Mepha 25 mg | | Tabletten | | N03AX09 | | Lamotrigine | | 14.07.2005 | | |
| | Composition | | lamotriginum 25 mg, calcii carbonas, sorbitolum 2.917 mg, cellulosum microcristallinum silicificatum, crospovidonum, maydis amylum, talcum, natrii stearylis fumaras, silica colloidalis anhydrica, aromatica, saccharinum natricum corresp. natrium 0.206 mg pro compresso. | | Packungsbestandteile | | Tablets | | | | | Active Agent | Dose |
|---|
| Lamotrigine | 25 mg |
| | BAG: Active Agent | Dose |
|---|
| Lamotrigine | 25 mg |
| | | | Inactive agents | Dose |
|---|
| Aromatica | | | Calcium Carbonate | | | Cellulosum Microcristallinum Silicificatum | | | Crospovidonum | | | Maydis Amylum | | | Natrii Stearylis Fumaras | | | Pro Compresso | | | Saccharinum Natricum | | | Silica Colloidalis Anhydrica | | | Sorbitol | 2.917 mg | | Talcum | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 010 | 60 Tablet(s) | 7.58 | 17.45 | B | SL | No |
|
|
